Sapphire Biotech

Sapphire Biotech is owned by Axim Biotech.

Axim Biotech is a company listed under the stock ticker AXIM (US).

View the org chart displaying its 3 main executives

Most searched biographies at Sapphire Biotech

• Catalina Valencia, Chief Executive Officer
• Sergei Svarovsky, Chief Scientific Officer
• Alim Seit-nebi, Chief Technology Officer

Create your alert
to follow the executive moves at Sapphire Biotech.

Axim Biotech has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Sapphire Biotech

Social media about Sapphire Biotech

• Sapphire Biotech on Wikipedia, Google News & Yahoo Finance
• Sapphire Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including Catalina Valencia

Call Sapphire Biotech at +1 858...

View the org chart

Register to receive your alert

Report an error